Clinical Trial Update: Safety and Efficacy of Romidepsin and the Therapeutic Vaccine Vacc-4x for Reduction of the Latent HIV-1 Reservoir [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study evaluating romidepsin in combination with the Vacc-4x therapeutic HIV vaccine for reducing the latent HIV reservoir; results were posted in 2017…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Romidepsin (romidepsin)
• Vacc-4x

Snippet

Sponsor: Bionor Immuno AS | Conditions: HIV I Infection | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-03-01